Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts

BACKGROUND: No comparisons of different doses of docetaxel-capecitabine in patients with advanced gastric cancer have been performed. METHODS: Patients with previously untreated metastatic/locally advanced gastro-oesophageal or gastric adenocarcinoma were enrolled in a prospective multicentre phase...

Descripción completa

Detalles Bibliográficos
Autores principales: Thuss-Patience, P C, Kretzschmar, A, Dogan, Y, Rothmann, F, Blau, I, Schwaner, I, Breithaupt, K, Bichev, D, Grothoff, M, Grieser, C, Reichardt, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170974/
https://www.ncbi.nlm.nih.gov/pubmed/21792201
http://dx.doi.org/10.1038/bjc.2011.278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170974/
https://www.ncbi.nlm.nih.gov/pubmed/21792201
http://dx.doi.org/10.1038/bjc.2011.278

Ejemplares similares